![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: RPS6 |
Gene summary for RPS6 |
![]() |
Gene information | Species | Human | Gene symbol | RPS6 | Gene ID | 6194 |
Gene name | ribosomal protein S6 | |
Gene Alias | S6 | |
Cytomap | 9p22.1 | |
Gene Type | protein-coding | GO ID | GO:0000003 | UniProtAcc | A2A3R6 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
6194 | RPS6 | GSM4909280 | Human | Breast | Precancer | 7.49e-05 | -3.79e-01 | 0.0305 |
6194 | RPS6 | GSM4909281 | Human | Breast | IDC | 4.24e-17 | -1.50e-01 | 0.21 |
6194 | RPS6 | GSM4909286 | Human | Breast | IDC | 3.94e-25 | 1.60e-01 | 0.1081 |
6194 | RPS6 | GSM4909287 | Human | Breast | IDC | 1.42e-84 | -6.29e-01 | 0.2057 |
6194 | RPS6 | GSM4909290 | Human | Breast | IDC | 7.14e-13 | 1.40e-01 | 0.2096 |
6194 | RPS6 | GSM4909291 | Human | Breast | IDC | 1.84e-09 | -1.73e-01 | 0.1753 |
6194 | RPS6 | GSM4909292 | Human | Breast | IDC | 1.88e-11 | -4.59e-01 | 0.1236 |
6194 | RPS6 | GSM4909293 | Human | Breast | IDC | 2.71e-08 | -8.06e-02 | 0.1581 |
6194 | RPS6 | GSM4909294 | Human | Breast | IDC | 3.50e-18 | -1.87e-01 | 0.2022 |
6194 | RPS6 | GSM4909295 | Human | Breast | IDC | 2.81e-03 | -1.68e-01 | 0.0898 |
6194 | RPS6 | GSM4909297 | Human | Breast | IDC | 1.10e-09 | -1.58e-01 | 0.1517 |
6194 | RPS6 | GSM4909298 | Human | Breast | IDC | 3.21e-28 | -1.58e-01 | 0.1551 |
6194 | RPS6 | GSM4909301 | Human | Breast | IDC | 3.68e-55 | -3.12e-01 | 0.1577 |
6194 | RPS6 | GSM4909303 | Human | Breast | IDC | 2.51e-05 | -2.46e-01 | 0.0438 |
6194 | RPS6 | GSM4909304 | Human | Breast | IDC | 1.05e-91 | -3.68e-01 | 0.1636 |
6194 | RPS6 | GSM4909306 | Human | Breast | IDC | 4.03e-16 | -1.44e-01 | 0.1564 |
6194 | RPS6 | GSM4909311 | Human | Breast | IDC | 1.12e-03 | -1.13e-01 | 0.1534 |
6194 | RPS6 | GSM4909315 | Human | Breast | IDC | 3.54e-99 | -5.93e-01 | 0.21 |
6194 | RPS6 | GSM4909316 | Human | Breast | IDC | 3.56e-56 | -9.90e-01 | 0.21 |
6194 | RPS6 | GSM4909317 | Human | Breast | IDC | 3.17e-66 | -4.72e-01 | 0.1355 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:004578718 | Thyroid | PTC | positive regulation of cell cycle | 144/5968 | 313/18723 | 9.93e-08 | 1.99e-06 | 144 |
GO:0032869111 | Thyroid | PTC | cellular response to insulin stimulus | 100/5968 | 203/18723 | 1.70e-07 | 3.19e-06 | 100 |
GO:0032868111 | Thyroid | PTC | response to insulin | 124/5968 | 264/18723 | 1.87e-07 | 3.47e-06 | 124 |
GO:0034101113 | Thyroid | PTC | erythrocyte homeostasis | 69/5968 | 129/18723 | 2.85e-07 | 4.90e-06 | 69 |
GO:001810518 | Thyroid | PTC | peptidyl-serine phosphorylation | 143/5968 | 315/18723 | 2.94e-07 | 5.04e-06 | 143 |
GO:001820916 | Thyroid | PTC | peptidyl-serine modification | 151/5968 | 338/18723 | 4.61e-07 | 7.51e-06 | 151 |
GO:004593119 | Thyroid | PTC | positive regulation of mitotic cell cycle | 65/5968 | 121/18723 | 5.08e-07 | 8.26e-06 | 65 |
GO:0031667113 | Thyroid | PTC | response to nutrient levels | 201/5968 | 474/18723 | 7.00e-07 | 1.10e-05 | 201 |
GO:0048872113 | Thyroid | PTC | homeostasis of number of cells | 125/5968 | 272/18723 | 7.25e-07 | 1.14e-05 | 125 |
GO:00000829 | Thyroid | PTC | G1/S transition of mitotic cell cycle | 102/5968 | 214/18723 | 9.48e-07 | 1.43e-05 | 102 |
GO:0002262113 | Thyroid | PTC | myeloid cell homeostasis | 79/5968 | 157/18723 | 1.11e-06 | 1.64e-05 | 79 |
GO:0043620113 | Thyroid | PTC | regulation of DNA-templated transcription in response to stress | 34/5968 | 53/18723 | 1.36e-06 | 1.95e-05 | 34 |
GO:00448439 | Thyroid | PTC | cell cycle G1/S phase transition | 112/5968 | 241/18723 | 1.37e-06 | 1.96e-05 | 112 |
GO:005160420 | Thyroid | PTC | protein maturation | 132/5968 | 294/18723 | 1.71e-06 | 2.39e-05 | 132 |
GO:0043281113 | Thyroid | PTC | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 99/5968 | 209/18723 | 1.93e-06 | 2.64e-05 | 99 |
GO:00457867 | Thyroid | PTC | negative regulation of cell cycle | 166/5968 | 385/18723 | 1.93e-06 | 2.64e-05 | 166 |
GO:0030218113 | Thyroid | PTC | erythrocyte differentiation | 63/5968 | 120/18723 | 2.14e-06 | 2.89e-05 | 63 |
GO:2000116113 | Thyroid | PTC | regulation of cysteine-type endopeptidase activity | 108/5968 | 235/18723 | 3.99e-06 | 4.99e-05 | 108 |
GO:0052547113 | Thyroid | PTC | regulation of peptidase activity | 191/5968 | 461/18723 | 7.82e-06 | 9.02e-05 | 191 |
GO:00435557 | Thyroid | PTC | regulation of translation in response to stress | 16/5968 | 20/18723 | 1.31e-05 | 1.42e-04 | 16 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0301018 | Breast | Precancer | Ribosome | 80/684 | 167/8465 | 7.33e-44 | 2.32e-41 | 1.77e-41 | 80 |
hsa0517118 | Breast | Precancer | Coronavirus disease - COVID-19 | 81/684 | 232/8465 | 3.74e-32 | 2.36e-30 | 1.81e-30 | 81 |
hsa0471418 | Breast | Precancer | Thermogenesis | 68/684 | 232/8465 | 4.40e-22 | 1.26e-20 | 9.69e-21 | 68 |
hsa0406616 | Breast | Precancer | HIF-1 signaling pathway | 23/684 | 109/8465 | 1.51e-05 | 1.59e-04 | 1.22e-04 | 23 |
hsa0520514 | Breast | Precancer | Proteoglycans in cancer | 30/684 | 205/8465 | 1.00e-03 | 7.18e-03 | 5.50e-03 | 30 |
hsa0301019 | Breast | Precancer | Ribosome | 80/684 | 167/8465 | 7.33e-44 | 2.32e-41 | 1.77e-41 | 80 |
hsa0517119 | Breast | Precancer | Coronavirus disease - COVID-19 | 81/684 | 232/8465 | 3.74e-32 | 2.36e-30 | 1.81e-30 | 81 |
hsa0471419 | Breast | Precancer | Thermogenesis | 68/684 | 232/8465 | 4.40e-22 | 1.26e-20 | 9.69e-21 | 68 |
hsa0406617 | Breast | Precancer | HIF-1 signaling pathway | 23/684 | 109/8465 | 1.51e-05 | 1.59e-04 | 1.22e-04 | 23 |
hsa0520515 | Breast | Precancer | Proteoglycans in cancer | 30/684 | 205/8465 | 1.00e-03 | 7.18e-03 | 5.50e-03 | 30 |
hsa0301024 | Breast | IDC | Ribosome | 83/867 | 167/8465 | 6.07e-39 | 9.87e-37 | 7.38e-37 | 83 |
hsa0517124 | Breast | IDC | Coronavirus disease - COVID-19 | 86/867 | 232/8465 | 1.50e-28 | 9.72e-27 | 7.27e-27 | 86 |
hsa0471424 | Breast | IDC | Thermogenesis | 75/867 | 232/8465 | 8.41e-21 | 3.04e-19 | 2.27e-19 | 75 |
hsa0520523 | Breast | IDC | Proteoglycans in cancer | 42/867 | 205/8465 | 7.69e-06 | 9.99e-05 | 7.48e-05 | 42 |
hsa0406623 | Breast | IDC | HIF-1 signaling pathway | 22/867 | 109/8465 | 1.36e-03 | 1.00e-02 | 7.50e-03 | 22 |
hsa0301034 | Breast | IDC | Ribosome | 83/867 | 167/8465 | 6.07e-39 | 9.87e-37 | 7.38e-37 | 83 |
hsa0517134 | Breast | IDC | Coronavirus disease - COVID-19 | 86/867 | 232/8465 | 1.50e-28 | 9.72e-27 | 7.27e-27 | 86 |
hsa0471434 | Breast | IDC | Thermogenesis | 75/867 | 232/8465 | 8.41e-21 | 3.04e-19 | 2.27e-19 | 75 |
hsa0520533 | Breast | IDC | Proteoglycans in cancer | 42/867 | 205/8465 | 7.69e-06 | 9.99e-05 | 7.48e-05 | 42 |
hsa0406633 | Breast | IDC | HIF-1 signaling pathway | 22/867 | 109/8465 | 1.36e-03 | 1.00e-02 | 7.50e-03 | 22 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
RPS6 | SNV | Missense_Mutation | novel | c.707N>T | p.Ser236Phe | p.S236F | P62753 | protein_coding | tolerated(0.06) | possibly_damaging(0.485) | TCGA-5L-AAT1-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Hormone Therapy | letrozol | SD |
RPS6 | SNV | Missense_Mutation | c.416G>A | p.Ser139Asn | p.S139N | P62753 | protein_coding | tolerated(0.23) | benign(0.071) | TCGA-A8-A09Z-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
RPS6 | SNV | Missense_Mutation | c.279N>C | p.Lys93Asn | p.K93N | P62753 | protein_coding | deleterious(0.01) | benign(0.425) | TCGA-C8-A12P-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
RPS6 | SNV | Missense_Mutation | rs767919541 | c.7N>G | p.Leu3Val | p.L3V | P62753 | protein_coding | deleterious(0.03) | benign(0.422) | TCGA-EW-A6SD-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | tch | SD |
RPS6 | SNV | Missense_Mutation | novel | c.707C>G | p.Ser236Cys | p.S236C | P62753 | protein_coding | deleterious(0.03) | possibly_damaging(0.7) | TCGA-OL-A5RW-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | CR |
RPS6 | SNV | Missense_Mutation | c.571N>T | p.Arg191Cys | p.R191C | P62753 | protein_coding | tolerated(0.22) | benign(0.022) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
RPS6 | SNV | Missense_Mutation | c.686N>T | p.Ala229Val | p.A229V | P62753 | protein_coding | tolerated(0.11) | possibly_damaging(0.499) | TCGA-AA-3811-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | PD | |
RPS6 | SNV | Missense_Mutation | c.571C>T | p.Arg191Cys | p.R191C | P62753 | protein_coding | tolerated(0.22) | benign(0.022) | TCGA-D5-6930-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
RPS6 | SNV | Missense_Mutation | rs756253114 | c.574A>G | p.Ile192Val | p.I192V | P62753 | protein_coding | tolerated(0.13) | benign(0.009) | TCGA-G4-6588-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
RPS6 | SNV | Missense_Mutation | rs778272571 | c.380N>A | p.Thr127Asn | p.T127N | P62753 | protein_coding | tolerated(0.13) | benign(0.02) | TCGA-DY-A1DD-01 | Colorectum | rectum adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |